Heidi Nelson to Breast Neoplasms
This is a "connection" page, showing publications Heidi Nelson has written about Breast Neoplasms.
Connection Strength
6.138
-
Use of an Online Breast Cancer Risk Assessment and Patient Decision Aid in Primary Care Practices. J Womens Health (Larchmt). 2020 06; 29(6):763-769.
Score: 0.407
-
Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019 09 03; 322(9):868-886.
Score: 0.393
-
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019 08 20; 322(7):666-685.
Score: 0.392
-
Mammography Screening and Overdiagnosis. JAMA Oncol. 2016 Feb; 2(2):261-2.
Score: 0.306
-
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016 Feb 16; 164(4):244-55.
Score: 0.305
-
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016 Feb 16; 164(4):256-67.
Score: 0.305
-
Factors Associated With Rates of False-Positive and False-Negative Results From Digital Mammography Screening: An Analysis of Registry Data. Ann Intern Med. 2016 Feb 16; 164(4):226-35.
Score: 0.305
-
Mammography Decision Aid Reduces Decisional Conflict for Women in Their Forties Considering Screening. J Womens Health (Larchmt). 2015 Dec; 24(12):1013-20.
Score: 0.298
-
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2014 Feb 18; 160(4):255-66.
Score: 0.267
-
Rates and indications for surgical breast biopsies in a community-based health system. Am J Surg. 2014 Apr; 207(4):499-503.
Score: 0.262
-
Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Apr 16; 158(8):604-14.
Score: 0.252
-
Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012 May 01; 156(9):635-48.
Score: 0.236
-
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med. 2009 Nov 17; 151(10):703-15, W-226-35.
Score: 0.199
-
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009 Nov 17; 151(10):727-37, W237-42.
Score: 0.199
-
Estimating risk of breast cancer in carriers of BRCA1 and BRCA2 mutations: a meta-analytic approach. Stat Med. 2007 Apr 15; 26(8):1775-87.
Score: 0.166
-
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2005 Sep 06; 143(5):362-79.
Score: 0.149
-
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants. JAMA Netw Open. 2024 Apr 01; 7(4):e247421.
Score: 0.135
-
Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol. 2021 Sep; 28(9):4995-5004.
Score: 0.108
-
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium. Breast Cancer Res Treat. 2020 Jun; 181(3):487-497.
Score: 0.103
-
Second opinion strategies in breast pathology: a decision analysis addressing over-treatment, under-treatment, and care costs. Breast Cancer Res Treat. 2018 01; 167(1):195-203.
Score: 0.086
-
The diagnostic challenge of low-grade ductal carcinoma in situ. Eur J Cancer. 2017 07; 80:39-47.
Score: 0.084
-
Surgical implications and variability in the use of the flat epithelial atypia diagnosis on breast biopsy specimens. Breast. 2017 Aug; 34:34-43.
Score: 0.083
-
Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time? Ann Surg Oncol. 2017 May; 24(5):1234-1241.
Score: 0.081
-
Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study. BMJ. 2016 Jun 22; 353:i3069.
Score: 0.079
-
The Influence of Disease Severity of Preceding Clinical Cases on Pathologists' Medical Decision Making. Med Decis Making. 2017 01; 37(1):91-100.
Score: 0.077
-
Variability in Pathologists' Interpretations of Individual Breast Biopsy Slides: A Population Perspective. Ann Intern Med. 2016 05 17; 164(10):649-55.
Score: 0.077
-
Diagnostic concordance among pathologists interpreting breast biopsy specimens. JAMA. 2015 Mar 17; 313(11):1122-32.
Score: 0.072
-
Trends in breast biopsy pathology diagnoses among women undergoing mammography in the United States: a report from the Breast Cancer Surveillance Consortium. Cancer. 2015 May 01; 121(9):1369-78.
Score: 0.071
-
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response. Breast. 2015 Feb; 24(1):3-11.
Score: 0.071
-
Digitized whole slides for breast pathology interpretation: current practices and perceptions. J Digit Imaging. 2014 Oct; 27(5):642-8.
Score: 0.070
-
Second opinion in breast pathology: policy, practice and perception. J Clin Pathol. 2014 Nov; 67(11):955-60.
Score: 0.069
-
A framework for evaluating diagnostic discordance in pathology discovered during research studies. Arch Pathol Lab Med. 2014 Jul; 138(7):955-61.
Score: 0.069
-
Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies. Breast Cancer Res Treat. 2014 May; 145(1):165-75.
Score: 0.067
-
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013 Oct 09; 310(14):1455-61.
Score: 0.065
-
Development of a diagnostic test set to assess agreement in breast pathology: practical application of the Guidelines for Reporting Reliability and Agreement Studies (GRRAS). BMC Womens Health. 2013 Feb 05; 13:3.
Score: 0.062
-
Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations. Ann Intern Med. 2012 Jul 17; 157(2):104-13.
Score: 0.060
-
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012 May 01; 156(9):609-17.
Score: 0.059
-
Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002 Aug 21; 288(7):872-81.
Score: 0.030
-
Models in the development of clinical practice guidelines. Ann Intern Med. 2014 Dec 02; 161(11):812-8.
Score: 0.018